HANTZ FINANCIAL SERVICES, INC.
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1071061
SOUTHFIELD, MI
Position in VRTX
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$7,951,537
+$4,691,426 QoQ
Shares Held
17,807
+147.6% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
18 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026HANTZ FINANCIAL SERVICES, INC. holds $27,021,973 across 66 Biotechnology names. VRTX ranks #1 (29.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
17,807 | $7,951,537 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
17,673 | $5,847,465 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
61,685 | $3,986,701 | |
| 4 | ARGX |
Argenx SE
|
1,434 | $1,047,178 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
31,870 | $882,799 | |
| 6 | TECH |
BIO-TECHNE Corp
|
16,753 | $875,511 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
11,338 | $640,483 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
3,293 | $622,541 |
All Filings in VRTX
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,951,537 | 17,807 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $3,260,111 | 7,191 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $2,439,917 | 6,230 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $608,143 | 1,366 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $670,990 | 1,384 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $506,596 | 1,258 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $1,648,243 | 3,544 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,628,802 | 3,475 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $15,884 | 38 | Shares | Sole | 2024-08-06 | |
| 2023-12-31 | $15,461 | 38 | Shares | Sole | 2024-08-06 | |
| 2023-09-30 | $13,214 | 38 | Shares | Sole | 2024-08-06 | |
| 2023-06-30 | $13,372 | 38 | Shares | Sole | 2024-08-06 | |
| 2021-12-31 | $19,983 | 91 | Shares | Sole | 2024-08-06 | |
| 2021-09-30 | $18,139 | 100 | Shares | Sole | 2024-08-06 | |
| 2021-06-30 | $503,066 | 2,495 | Shares | Sole | 2024-08-06 | |
| 2021-03-31 | $395,182 | 1,839 | Shares | Sole | 2024-08-06 | |
| 2020-12-31 | $271,081 | 1,147 | Shares | Sole | 2024-08-06 | |
| 2020-09-30 | $106,671 | 392 | Shares | Sole | 2024-08-06 | |
| No filing history on record for this holder in this stock. | ||||||